CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Inhibrx gains as Stifel issues new Buy based on lead assets

Positive
AI Analysis

Summary

Stifel initiated a new Buy rating on Inhibrx based on the company's lead assets. The stock gained on the analyst upgrade.

Importance:3/10
Sentiment:
0.60
analyst_upgraderatingequities
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on April 8, 2026 4:10 PM

Read Original